Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3 - Feenstra, H; van Dijk, E; van Rijssen, T (Graefes Arch Clin Exp Ophthalmol, 2023)